Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Mallinckrodt
Baxter
McKinsey
Moodys

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Exisulind

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Exisulind?

Exisulind is an investigational drug.

There have been 12 clinical trials for Exisulind. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2001.

The most common disease conditions in clinical trials are Prostatic Neoplasms, Lung Neoplasms, and Carcinoma, Non-Small-Cell Lung. The leading clinical trial sponsors are National Cancer Institute (NCI), OSI Pharmaceuticals, and Alliance for Clinical Trials in Oncology.

Recent Clinical Trials for Exisulind
TitleSponsorPhase
Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate CancerNational Cancer Institute (NCI)Phase 2
Exisulind Versus Placebo After Surgical Removal of the ProstateOSI PharmaceuticalsPhase 2
Exisulind Versus Placebo After Surgical Removal of the ProstateMayo ClinicPhase 2

See all Exisulind clinical trials

Clinical Trial Summary for Exisulind

Top disease conditions for Exisulind
Top clinical trial sponsors for Exisulind

See all Exisulind clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
AstraZeneca
Dow
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.